Insulet Corporation (PODD) Misses Q3 EPS by 5c; Guides Slightly Below for FY Revs
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Join SI Premium – FREE
Insulet Corporation (NASDAQ: PODD) reported Q3 EPS of ($0.29), $0.05 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $44.6 million versus the consensus estimate of $45 million.
Insulet Corporation sees FY2011 revenue of $150-$154 million, versus the consensus of $154.81 million.
Insulet Corporation sees FY2011 revenue of $150-$154 million, versus the consensus of $154.81 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
- Reading (RDI) Tops Q2 EPS by 4c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
